HYDERABAD, India and WESTBOROUGH, Mass., June 26 /PRNewswire-FirstCall/ -- Satyam Computer Services Ltd. , a leading global consulting and information technology services provider, announced today that it has formed an alliance with Sciformix Corporation, a Westborough, Mass.-based, Life Science Knowledge Process Outsourcing (KPO) company, to deliver end-to-end data management services in "Pharmacovigilance."
The partnership addresses the worldwide increase in focus on drug safety, which is leading to increased volumes of adverse events being reported to the regulatory authorities. Satyam and Sciformix will collaborate to enable pharmaceutical and biotechnology companies to better monitor the safety of the products they market by offering services across the safety management spectrum, ranging from case intake to international regulatory reporting. The alliance also enables the organizations to offer these services in a way that is both cost-efficient and scalable, via a proven global delivery model.
Additionally, the alliance leverages Sciformix's in-depth understanding of the pharmaceutical and life sciences domain with Satyam's proven drug safety Business Process Outsourcing (BPO) capabilities. It will provide services to a wide range of clients in the pharmaceutical, biotechnology and life sciences industries.
"We are very pleased by this partnership. Sciformix has deep expertise delivering end-to-end safety management services, from adverse event intake to regulatory submissions," said Kishore Rachapudi, Satyam's global head of life sciences. "We will leverage our extensive experience managing large-scale IT and BPO solutions and work with Sciformix to offer a scalable platform for delivery of drug safety services. At the same time, we reaffirm our commitment to providing the widest range of services through the most advanced global delivery models available."
Several high-profile withdrawals of popular drugs from the marketplace have also made this partnership more important. The withdrawals have pharmaceutical companies looking for ways to manage risk and taking a more proactive approach toward collection and assessment of drug safety information.
"These are some of the most important reasons we have formed this partnership," said Dinesh Thakur, president and Chief Executive Officer of Sciformix, "Satyam brings years of experience delivering outsourced services to global customers. Its large-scale global delivery services capacity and experience in the life sciences industry, along with Sciformix's deep domain expertise, offer global pharmaceutical, biotechnology and life sciences companies a unique alliance for delivery of high-quality services."
Satyam , a leading global business and information technology services company, delivers consulting, systems integration, and outsourcing solutions to clients in 20* industries and 63* countries.
Satyam leverages deep industry and functional expertise, leading technology practices, and an advanced, global delivery model to help clients transform their highest-value business processes and improve their business performance. The company's 51,127* professionals excel in engineering and product development, supply chain management, client relationship management, business process quality, business intelligence, enterprise integration, and infrastructure management, among other key capabilities.
Satyam development and delivery centers in the US, Canada, Brazil, the UK, Hungary, Egypt, UAE, India, China, Malaysia, Singapore, and Australia serve 654* clients, including more than one third of the Fortune 500. For more information, see www.satyam.com.
*As of March 31, 2008
About Sciformix Corporation
Founded in the U.S. with headquarters in Westborough, MA, and a Pharmacovigilance Center of Excellence in Mumbai, India, Sciformix is a fast growing knowledge process outsourcing (KPO) company providing drug safety data management, clinical data management, biostatistics & programming and medical writing services to pharmaceutical, biotechnology and life science companies globally. Sciformix has an experienced leadership team driving its rapid growth and expansion. For more information on Sciformix, please visit www.sciformix.com.
This press release contains forward-looking statements within the meaning of section 27A of Securities Act of 1933, as amended, and section 21E of the Securities Exchange Act of 1934, as amended. The forward-looking statements contained herein are subject to certain risks and uncertainties that could cause actual results to differ materially from those reflected in the forward- looking statements. Satyam undertakes no duty to update any forward-looking statements. For a discussion of the risks associated with our business, please see the discussions under the heading "Risk Factors" in our report on Form 6-K concerning the quarter ended December 31, 2007, furnished to the United States Securities Exchange Commission on January 28, 2008 and the other reports filed with the Securities Exchange Commission from time to time. These filings are available at http://www.sec.gov.
This announcement is not an offer of securities for sale in the United States. Securities may not be offered or sold in the United States absent registration or an exemption from registration. Any public offering of securities to be made in the United States will be made by means of a prospectus that may be obtained from Satyam and that will contain detailed information about Satyam and its management, as well as financial statements.
CONTACT: Rajiv Prasad, AVP Life Sciences of Satyam Computers Limited,
Rajiv_Prasad@satyambpo.com, or Jeffrey S. Yablon, Vice President, Sales &
Marketing of Sciformix Corporation, firstname.lastname@example.org; Satyam
Contacts: India, Meigha Humbre, email@example.com, +91-970-360-8822
or Rachna Pandey, Rachna_pandey@satyam.com, +91-970-303-8743; US, Jim
Swords, firstname.lastname@example.org, +1-703-877-2225; Europe, Sandeep Thawani,
email@example.com, +44-20-7309-1037; Asia-Pacific, Dan Bleakman,
Dan@howorth.com.au, +61-439-408-484 or Reshma Wad Jain, Reshma@wer1.net,
Web site: http://www.satyam.com/